A patient with acute promyelocytic leukemia (APL) and laboratory evidence of fibrinolysis who could not be treated with aggressive cytostatic regimens because of Aspergillus pneumonia was treated with cis-retinoic acid (RA), a substance that can induce differentiation and maturation of APL cells. After seven weeks of daily oral treatment, he went into complete remission, and signs of coagulopathy disappeared. Meanwhile, the Aspergillus pneumonia could be treated adequately. Based on the experience in this single patient, RA deserves further evaluation in the treatment of APL.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
aspergillus pneumonia
12
patient acute
8
acute promyelocytic
8
promyelocytic leukemia
8
pneumonia treated
8
retinoic acid
4
acid antileukemic
4
antileukemic therapy
4
therapy patient
4
leukemia aspergillus
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!